Medichoice Bacitracin Ointment
NDC Package 39892-0810-3
Package Information
Medichoice Bacitracin (bacitracin) ointment is a medication an antibiotic used to treat certain bacterial eye infections. This formulation utilizes a ointment delivery system. Marketed by O&m Halyard, Inc., this product is identified by NDC 39892-0810 and is authorized under FDA application M004.
Identification & Billing
- RxCUI: 1648110 - bacitracin 500 UNT in GM Topical Ointment
- RxCUI: 1648110 - bacitracin 0.5 UNT/MG Topical Ointment
- RxCUI: 1648110 - bacitracin 500 UNT per GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 39892 - O&m Halyard, Inc.
- 39892-0810 - Medichoice Bacitracin
- 39892-0810-3 - 1 TUBE in 1 CARTON / 28.35 g in 1 TUBE
- 39892-0810 - Medichoice Bacitracin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (39892-0810). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 39892-0810-3 identifies a specific commercial package of 1 tube in 1 carton / 28.35 g in 1 tube of Medichoice Bacitracin, a human over the counter drug labeled by O&m Halyard, Inc.. This ointment is formulated for topical use and contains bacitracin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by O&m Halyard, Inc. on March 26, 2015. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.
How is this O&m Halyard, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 39892081003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.